EUDA Health Holdings Ltd

Listed Company

EUDACIK 0001847846NasdaqNon-AcceleratedEmerging GrowthServices-Health ServicesD8VGFY ends Dec 31

Period

FY 2025

Revenue

$6.82M

Net Income

$-2.77M

Total Assets

$1.72M

Equity

$-4.25M

Shares Out

1.89M

Op. Cash Flow

$-2.43M

Business

EUDA Health Holdings Ltd provides non-invasive healthcare and wellness services focused on preventive and regenerative therapies. It offers bioenergy cabin therapy packages, direct sales of proprietary wellness products through its CK Health acquisition, and distribution arrangements for stem cell therapy services rendered at third-party treatment centers. The company operates property management services as a primary business segment while maintaining a medical and wellness services division for direct sales and collaborations. EUDA targets markets across Southeast Asia and China using omni-channel distribution, partnerships, clinic networks, and digital platforms.

Summary from filing dated 2025-04-29

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2022 2022-12-31	FY 2022 2022-07-31	FY 2021 2021-12-31
Total Revenues	10	—	11
Total Cost of Revenues	6	—	6
GROSS PROFIT	3	—	4
Selling	2	—	1
General and administrative	7	—	4
Earnout share payment	5	—	—
Impairment loss on long-lived assets and goodwill	1	—	—
Research and development	17,209	—	129,265
Total Operating Expenses	15	—	5
LOSS FROM OPERATIONS	−12	−2	−1
Interest expense, net	−120,082	—	−127,126
Gain on disposal of subsidiary	30,055	—	—
Change in fair value of prepaid forward purchase liabilities	−13	—	—
Other income, net	127,477	—	386,828
Investment income	—	—	2
Total Other Income (Expense), net	−13	222,912	2
(LOSS) INCOME BEFORE INCOME TAXES	−25	—	948,537
PROVISION FOR INCOME TAXES	17,422	—	48,141
NET (LOSS) INCOME	−25	—	900,396
Less: Net (income) loss attributable to noncontrolling interest	−65,124	—	35,567
NET (LOSS) INCOME ATTRIBUTABLE TO EUDA HEALTH HOLDINGS LIMITED	−25	−2	864,829
FOREIGN CURRENCY TRANSLATION ADJUSTMENT	−131,941	—	17,009
TOTAL COMPREHENSIVE (LOSS) INCOME	−25	—	917,405
Less: Comprehensive (loss) income attributable to noncontrolling interest	−65,340	—	35,584
COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO EUDA HEALTH HOLDINGS LIMIT	−25	—	881,821
Basic and diluted (shares)	12	—	9
Basic and diluted (per share)	−2.07	—	0.09

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2022 2022-12-31	FY 2022 2022-10-31	FY 2022 2022-07-31	FY 2021 2021-12-31	FY 2021 2021-07-31
Cash	143,024	—	193,546	189,996	—
Restricted cash	641,461	—	—	—	—
Accounts receivable, net	2	—	—	2	—
Other receivables	7,467	—	—	2	—
Due from related parties	267,863	—	—	297,621	—
Prepaid expenses and other current assets	222,633	—	—	71,495	—
Forward purchase receivables	22	—	—	—	—
Total Current Assets	25	—	87	4	428,920
PROPERTY AND EQUIPMENT, NET	31,628	—	—	56,927	—
Other receivables - non-current	—	—	—	2	—
Prepaid expenses - non-current	478,061	—	—	—	—
Intangible assets, net	—	—	—	289,962	—
Goodwill	—	—	—	992,686	—
Operating lease right-of-use asset	76,528	—	—	79,862	—
Finance lease right-of-use assets	16,345	—	—	24,372	—
Loan to third party	—	—	—	371,962	—
Total Other Assets	570,934	—	—	4	—
Total Assets	26	—	87	8	428,920
Short term loans - bank and private lender	204,240	—	—	205,427	—
Short term loans - third parties	—	—	—	148,302	—
Promissory note	170,000	—	—	—	—
Convertible notes	3	—	—	—	—
Convertible notes - related parties	782,600	—	—	—	—
Accounts payable	2	—	—	359,716	—
Accounts payable - related party	—	—	—	2	—
Other payables and accrued liabilities	2	—	—	488,597	—
Other payables - related parties	2	—	—	3	—
Operating lease liability	79,959	—	—	63,478	—
Finance lease liabilities	7,186	—	—	11,447	—
Prepaid forward purchase liabilities	20	7	—	—	—
Taxes payable	186,150	—	—	307,343	—
Total Current Liabilities	29	—	—	7	—
Deferred tax liabilities	—	—	—	49,294	—
Operating lease liability - non-current	—	—	—	16,384	—
Finance lease liabilities - non-current	15,015	—	—	17,268	—
Total Other Liabilities	15,015	—	—	82,946	—
Total Liabilities	29	—	5	7	399,797
COMMITMENTS AND CONTINGENCIES	—	—	—	—	—
Ordinary shares, no par value, unlimited shares authorized, 20,191,770 shares and 9,333,333 shares outstanding as of December 31, 2022 and 2021, respectively	21	—	—	334,863	—
Retained earnings (accumulated deficit)	−25	—	−4	180,333	−8,377
Accumulated other comprehensive (loss) income	−125,689	—	—	6,036	—
Total Euda Health Holdings Limited Shareholders (Deficit) Equity	−4	—	−4	521,232	29,123
Noncontrolling interests	13,478	—	—	78,818	—
Total Shareholders (Deficit) Equity	−4	—	—	600,050	—
Total Liabilities and Shareholders (Deficit) Equity	26	—	87	8	428,920

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2022 2022-12-31	FY 2022 2022-07-31	FY 2021 2021-12-31
Depreciation	23,347	—	34,523
Amortization of intangible assets	115,907	—	162,825
Amortization of operating right-of-use asset	109,056	—	58,602
Amortization of finance right-of-use assets	7,948	—	8,153
Provision for doubtful accounts	3	—	43,804
Deferred taxes benefits	−48,228	—	−27,680
Earnout payment	5	—	—
Impairment loss on goodwill	971,229	—	—
Impairment loss on intangible assets	200,000	—	—
Change in fair value of prepaid forward purchase liabilities	13	—	—
Accounts receivable	−174,824	—	−263,950
Interest receivable from loan to third party	—	—	−19,071
Other receivables	2	—	55,692
Prepaid expenses and other current assets	−22,749	71,857	−18,010
Accounts payable	1	—	353,560
Accounts payables - related party	−2	—	1
Other payables and accrued liabilities	1	—	4,360
Taxes payable	−114,133	—	107,188
Operating lease liability	−105,719	—	−62,124
Net cash (used in) provided by operating activities	−2	−1	443,920
Purchases of equipment	−18,137	—	−1,957
Loan to third party	−246,664	—	—
Cash acquired through business combination	—	—	−354,226
Cash released upon disposal of a subsidiary	−3,405	—	—
Net cash used in investing activities	−268,206	−86	−356,183
Issuance of ordinary shares	500,000	—	—
Capital contributions	600,000	—	—
Proceeds from the Reverse Recapitalization	1	—	—
Payments of merger costs	−1	—	—
Repayments from other receivable - related parties	30,670	—	36,189
Proceeds from short-term loans - bank and private lender	72,548	—	87,812
Repayments to short-term loans - bank and private lender	−74,895	—	−66,801
Repayments to short-term loans - third parties	—	—	−312,553
Borrowings from other payables - related parties	1	800,000	93,666
Payment of finance lease liabilities	−6,502	—	−6,686
Net cash provided by (used in) financing activities	2	87	−168,373
EFFECT OF EXCHANGE RATE CHANGES	−99,424	—	19,865
NET CHANGE IN CASH AND RESTRICTED CASH	594,489	193,546	−60,771
Cash paid for income tax	156,339	—	30,185
Cash paid for interest	19,588	—	110,835
Initial recognition of operating right of use asset and lease liability	105,350	—	125,834
Initial recognition of payables to former subsidiary upon disposal of subsidiary	319,158	—	—
Conversion of debt into a promissory note	170,000	—	—
Conversion of debts into convertible notes	206,500	—	—
Forgiveness of debt by a related party	3	—	—
Issuance of ordinary shares upon the Reverse Recapitalization	12	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro